NCT04513691

Brief Summary

This study will review practices in relation to chorioamnionitis (CAM) before and after to the implementation of the Neonatal Early-Onset Sepsis (EOS) Risk Calculator to determine the effect in the nursery at Banner - University Medical Center Phoenix. Newborns enrolled will be at least 35 weeks gestational age (GA) and have a maternal diagnosis of at least suspected or confirmed CAM. The data will include those newborns whose assessment and treatment were not guided by the EOS calculator which was implemented on August 28, 2019 and those with which the EOS calculator was utilized. A secondary objective is to show the economic impact with utilization of the EOS calculator. Data collected will include full laboratory workups including complete blood counts (CBC), blood cultures, antibiotic usage, length of time in the newborn nursery and total length of stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
236

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 14, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

September 30, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2022

Completed
Last Updated

November 22, 2022

Status Verified

September 1, 2022

Enrollment Period

1.9 years

First QC Date

August 6, 2020

Last Update Submit

November 17, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • To determine whether the usage of Neonatal EOS Calculator decreased antibiotic usage in newborns with a maternal diagnosis of suspected or confirmed chorioamnionitis (CAM) in our newborn nursery.

    To determine the usage of EOS Calculator measuring decreased antibiotic usage.

    August 28, 2018 through August 28, 2020

  • To determine whether the usage of Neonatal EOS Calculator measuring laboratory testing in newborns with a maternal diagnosis of suspected or confirmed chorioamnionitis (CAM) in our newborn nursery.

    To determine the usage of EOS Calculator measuring laboratory testing.

    August 28, 2018 through August 28, 2020

  • To determine whether the usage of Neonatal EOS Calculator LOS in newborns with a maternal diagnosis of suspected or confirmed chorioamnionitis (CAM) in our newborn nursery.

    To determine the usage of EOS Calculator measuring length of stay (LOS) in newborns

    August 28, 2018 through August 28, 2020

Secondary Outcomes (3)

  • To evaluate the economic impact after the implementation of the EOS Calculator in antibiotic usage in newborn nursery and total length of hospital stay.

    August 28, 2018 through August 28, 2020

  • To evaluate the economic impact after the implementation of the EOS Calculator in laboratory tests in newborn nursery and total length of hospital stay.

    August 28, 2018 through August 28, 2020

  • To evaluate the economic impact after the implementation of the EOS Calculator in LOS in newborn nursery and total length of hospital stay.

    August 28, 2018 through August 28, 2020

Study Arms (1)

Sample

Asymptomatic newborns 35 weeks or greater GA born at Banner - University Medical Center Phoenix whose mothers were determined or suspected to have CAM.

Diagnostic Test: EOS Calculator

Interventions

EOS CalculatorDIAGNOSTIC_TEST

Neonatal Early-Onset Sepsis Risk Calculator which is a tool that determines the risk of EOS for a particular newborn by looking at maternal risk factors and the newborn's clinical picture as opposed to just laboratory tests alone

Sample

Eligibility Criteria

Age35 Weeks+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Asymptomatic newborns 35 weeks or greater GA born at Banner - University Medical Center Phoenix April 28, 2018 through April 28, 2020 whose mothers were determined or suspected to have CAM.

You may qualify if:

  • Asymptomatic newborns 35 weeks or greater GA born at Banner - University Medical Center Phoenix whose mothers were determined or suspected to have CAM.

You may not qualify if:

  • Direct NICU Admissions
  • Subjects may be excluded at Investigator discretion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banner - University Medical Center Phoenix

Phoenix, Arizona, 85006, United States

Location

MeSH Terms

Conditions

ChorioamnionitisNeonatal Sepsis

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFetal Membranes, Premature RuptureObstetric Labor ComplicationsPlacenta DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSepsisInfectionsInfant, Newborn, DiseasesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2020

First Posted

August 14, 2020

Study Start

September 30, 2020

Primary Completion

August 10, 2022

Study Completion

August 10, 2022

Last Updated

November 22, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations